Shell J - Search Results

1

The utility of ⁶⁸Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

Shell J, Tirosh A, Millo C, Sadowski SM, Assadipour Y, Green P, Patel D, Nilubol N, Kebebew E. Shell J, et al. Eur J Radiol. 2019 Mar;112:130-135. doi: 10.1016/j.ejrad.2018.11.023. Epub 2018 Nov 22. Eur J Radiol. 2019. PMID: 30777201 Free PMC article.

2

The Rate and Clinical Significance of Incidental Thyroid Uptake as Detected by Gallium-68 DOTATATE Positron Emission Tomography/Computed Tomography.

Nockel P, Millo C, Keutgen X, Klubo-Gwiezdzinska J, Shell J, Patel D, Nilubol N, Herscovitch P, Sadowski SM, Kebebew E. Nockel P, et al. Among authors: shell j. Thyroid. 2016 Jun;26(6):831-5. doi: 10.1089/thy.2016.0174. Epub 2016 May 6. Thyroid. 2016. PMID: 27094616 Free PMC article.

3

Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total ⁶⁸Ga-DOTATATE-Avid tumor volume measurements.

Tirosh A, Papadakis GZ, Millo C, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, Green P, Keutgen XM, Patel D, Nilubol N, Kebebew E. Tirosh A, et al. Among authors: shell j. Eur J Endocrinol. 2017 May;176(5):575-582. doi: 10.1530/EJE-16-1079. Eur J Endocrinol. 2017. PMID: 28289088 Free PMC article.

4

Prognostic Utility of Total ⁶⁸Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.

Tirosh A, Papadakis GZ, Millo C, Hammoud D, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, Green P, Keutgen XM, Patel D, Nilubol N, Kebebew E. Tirosh A, et al. Among authors: shell j. Gastroenterology. 2018 Mar;154(4):998-1008.e1. doi: 10.1053/j.gastro.2017.11.008. Epub 2017 Nov 16. Gastroenterology. 2018. PMID: 29155309 Free PMC article.

5

68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.

Shell J, Keutgen XM, Millo C, Nilubol N, Patel D, Sadowski S, Boufraqech M, Yang L, Merkel R, Atallah C, Herscovitch P, Kebebew E. Shell J, et al. Int J Endocr Oncol. 2018 Feb 2;5(1):IJE04. doi: 10.2217/ije-2017-0005. eCollection 2018 Feb. Int J Endocr Oncol. 2018. PMID: 30112163 Free PMC article.

6

Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report.

Shell J, Patel D, Powers A, Quezado M, Killian K, Meltzer P, Zhu J, Gaitanidis A, Karzai F, Neychev V, Green P, Kebebew E. Shell J, et al. J Endocr Soc. 2017 Jul 7;1(9):1124-1134. doi: 10.1210/js.2017-00156. eCollection 2017 Sep 1. J Endocr Soc. 2017. PMID: 29264567 Free PMC article.

7

Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.

Boufraqech M, Patel D, Nilubol N, Powers A, King T, Shell J, Lack J, Zhang L, Gara SK, Gunda V, Klubo-Gwiezdzinska J, Kumar S, Fagin J, Knauf J, Parangi S, Venzon D, Quezado M, Kebebew E. Boufraqech M, et al. Among authors: shell j. Thyroid. 2019 Jan;29(1):79-92. doi: 10.1089/thy.2018.0424. Epub 2018 Dec 28. Thyroid. 2019. PMID: 30398411 Free PMC article.

8

Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma.

Gendron LN, Sheveland CG, Gunn JR, Pogue BW, Shell TA, Shell JR. Gendron LN, et al. Among authors: shell jr. Mol Pharm. 2024 Jan 1;21(1):137-142. doi: 10.1021/acs.molpharmaceut.3c00667. Epub 2023 Nov 21. Mol Pharm. 2024. PMID: 37989273

9

Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.

Ali SA, Shell J, Harris R, Bedder M. Ali SA, et al. Among authors: shell j. Harm Reduct J. 2023 Oct 5;20(1):144. doi: 10.1186/s12954-023-00878-8. Harm Reduct J. 2023. PMID: 37798673 Free PMC article.

10

MRI scarcity in low- and middle-income countries.

Jalloul M, Miranda-Schaeubinger M, Noor AM, Stein JM, Amiruddin R, Derbew HM, Mango VL, Akinola A, Hart K, Weygand J, Pollack E, Mohammed S, Scheel JR, Shell J, Dako F, Mhatre P, Kulinski L, Otero HJ, Mollura DJ. Jalloul M, et al. Among authors: shell j. NMR Biomed. 2023 Dec;36(12):e5022. doi: 10.1002/nbm.5022. Epub 2023 Aug 13. NMR Biomed. 2023. PMID: 37574441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page